Rinonex Nasal Spray (Mometasone Furoate)

Adult use

Allergic Rhinitis: Generally, spray twice in each nostril once daily (total daily dose 0.2 mg). If symptoms improve, the maintenance dose can be reduced to once in each nostril (total daily dose 0.1 mg). If symptoms do not improve, the dose can be increased to a maximum of four times in each nostril once daily (total daily dose 0.4 mg). Polyps: Generally, spray twice in each nostril once daily.

Child use

Allergic Rhinitis: Generally, spray once in each nostril once daily (total daily dose 0.1 mg).

This medication should not be used in certain patients. For example, patients who are allergic to this medication or have experienced hypersensitivity, patients with untreated nasal mucosal infections, those who have recently undergone nasal surgery or have nasal wounds, and infants under 2 years of age should not use this medication. Also, caution should be exercised when using this medication in patients with respiratory infections or tuberculosis, systemic infections, herpes simplex in the eyes, patients with recurrent nosebleeds, those at risk for chickenpox or measles infections, patients with specific polyps, women who are pregnant or may become pregnant, and breastfeeding mothers. While using this drug, various side effects may occur, including headache, viral infections, pharyngitis, nosebleeds, cough, upper respiratory infections, menstrual discomfort, muscle pain, sinusitis, vomiting, etc. Rarely, serious allergic reactions such as bronchospasm, difficulty breathing, or anaphylaxis may occur. If unusual symptoms appear, use should be immediately discontinued and medical advice sought. Long-term high-dose use may lead to systemic steroid side effects; thus, caution is needed, especially in patients with severe bacterial infection symptoms prompting immediate consultation with a physician. Additionally, if there is irritation or fungal infection in the nasal mucosa, treatment discontinuation or additional treatment may be necessary. This medication can affect growth, so regular growth monitoring is particularly necessary for children. Women who are pregnant or breastfeeding should use this medication carefully considering the risks to the fetus and infant. This medication may interact with other medications, especially when used with CYP3A4 inhibitors, increasing the risk of side effects, so medical consultation is advised. Before use, shake the container well and perform a test spray to ensure a uniform spray. Care should be taken not to spray directly into the eyes or the septum. Store out of reach of children and dispose of after the specified period. Finally, this medication may yield positive results on doping tests for athletes, so caution is needed.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, nosebleed, symptoms of anaphylaxis, generalized flushing, severe allergic reactions, high fever with severe rash, blisters, skin peeling, pain in oral/eye mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues associated with cough and fever, jaundice (yellowing of skin or eyes), generalized

Mild side effects

Headache, viral infections, pharyngitis, nosebleeds/blood-colored mucus, cough, upper respiratory infections, menstrual discomfort, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, indigestion, earache, cold symptoms, muscle pain, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), pharyngeal symptoms (irritation

This medication should be stored in an airtight container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 2 and 25 degrees Celsius.

Appearance

An opaque white or almost white suspension in a container that delivers a measured amount of spray.

Package unit

18 grams/bottle